Literature DB >> 24693996

Cell-based assay system to estimate the effect of 125I seeds on cancer cells: effect of osteopontin.

Guang Yang, Sheng Peng, Yanling Zhang, Zhenyin Liu, Mingjian Lu, Tao Zhang, Fei Gao, Fujun Zhang1.   

Abstract

BACKGROUND AND
PURPOSE: A number of recent patents related to 125I seed and osteopontin have been awarded. In this study, we developed a new in vitro model to study the radiobiological effects of 125I seeds on cancer cells.
METHODS: We placed 125I seeds in a cell culture plate with cells seeded on a transwell chamber to evaluate the effects of 125I seeds on cell motility. We placed 125I seeds in a transwell chamber with cells seeded on the cell culture plate to study cell proliferation, apoptosis, and to perform western blot.
RESULTS: We used SK-Hep-1 liver cancer cells to evaluate the effectiveness of our model, and investigated the role of osteopontin in the therapeutic effects of 125I seeds. We found that 125I seeds inhibited the cell proliferation and motility in this model while osteopontin reduced these effects. We also measured the effects of 125I seeds on apoptosis. Furthermore, when treated with 125I seeds, we detected changes in several signaling pathways that are involved in the proliferation and invasion of cancer cells.
CONCLUSIONS: The model can be used to assess the biological effects of 125I seeds in vitro. Osteopontin may be involved in the 125I seed-induced inhibition of SK-Hep-1 cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24693996     DOI: 10.2174/1574892809666140331151747

Source DB:  PubMed          Journal:  Recent Pat Anticancer Drug Discov        ISSN: 1574-8928            Impact factor:   4.169


  5 in total

1.  125I Seed Brachytherapy Combined with Single-Agent Chemotherapy in the Treatment of Non-Small-Cell Lung Cancer in the Elderly: A Valuable Solution.

Authors:  Tian-Hua Yue; Wei Xing
Journal:  Onco Targets Ther       Date:  2020-10-16       Impact factor: 4.147

2.  CT-guided 125I brachytherapy for recurrent ovarian cancer.

Authors:  Ping Liu; Lina Tong; Bin Huo; Dong Dai; Wenxin Liu; Ke Wang; Ying Wang; Zhi Guo; Hong Ni
Journal:  Oncotarget       Date:  2017-03-04

3.  A Robust Oxygen Microbubble Radiosensitizer for Iodine-125 Brachytherapy.

Authors:  Sheng Peng; Ruyuan Song; Qingguang Lin; Yanling Zhang; Yuanzhong Yang; Ma Luo; Zhihui Zhong; Xiaonan Xu; Ligong Lu; Shuhuai Yao; Fujun Zhang
Journal:  Adv Sci (Weinh)       Date:  2021-02-10       Impact factor: 16.806

4.  125I Seed Promotes Apoptosis in Non-small Lung Cancer Cells via the p38 MAPK-MDM2-p53 Signaling Pathway.

Authors:  Tao Zhang; ZhiQiang Mo; Guangfeng Duan; Rijie Tang; Fujun Zhang; Mingjian Lu
Journal:  Front Oncol       Date:  2021-04-21       Impact factor: 6.244

5.  The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy.

Authors:  Zhanwang Xiang; Zhihui Zhong; Luwen Mu; Guohong Li; Churen Zhou; Haofan Wang; Mingsheng Huang
Journal:  Cancer Manag Res       Date:  2021-07-05       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.